[ Visit Client Website ]

Before you can access ASH's online program, you must agree to the following:
  • Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
  • The media, companies and institutions issuing press releases, and others are required to abide by the embargo policies governing the Society’s annual meeting. Read ASH’s embargo policy for more information.
-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session .

Plenary Scientific Session

Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 9, 2012: 2:00 PM-4:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)
2:00 PM

Walter Sunny Dzik, MD

Blood Transfusion Service, Harvard University, Boston, MA

2:05 PM

Simon J. Stanworth, MRCP, FRCPath, DPhil1*, Lise Estcourt, MB BChir2*, Gillian Powter, RN, BA Health Care Studies2*, Brennan C. Kahan, MSc3,4*, Claire Dyer, RN, BN5*, Lekha Bakrania, BSc6*, Charlotte Llewelyn, PhD3*, Louise Choo, PhD3,7*, Linley Bielby, RN, MHA8*, Derek Norfolk, MBBS, FRCP, FRCPath9*, Erica M. Wood, MBBS10* and Michael F. Murphy, MD, FRCP, FRCPath2

1John Radcliffe Hospital, NHS Blood and Transplant, Oxford University Hospital NHS Trust, Oxford, United Kingdom
2NHS Blood and Transplant, Oxford OX3 9BQ, United Kingdom
3NHS Blood and Transplant, Cambridge CB2 0PT, United Kingdom
4Clinical Trials Unit, Medical Research Council, London WC2B 6NH, United Kingdom
5NHS Blood and Transplant, Oxford OX3 9BQ
6NHS Blood and Transplant, Cambridge CB2 0PT, United Kingdom
7Clinical Trials Unit, Medical Research Council
8Department of Health, Australian Red Cross Blood Service, Melbourne, Australia
9NHS Blood and Transplant, Leeds LS15 7TW, United Kingdom
10Transfusion Medicine Services, Australian Red Cross Blood Service, Melbourne, Australia

2:20 PM

Michelle M. Le Beau, PhD

University of Chicago Comprehensive Cancer Center, Chicago, IL

2:25 PM

Hideki Makishima, MD, PhD1, Kenichi Yoshida, MD2*, Nhu Nguyen, PhD3*, Masashi Sanada, MD2*, Yusuke Okuno, MD, PhD2*, Kwok Peng Ng, PhD4, Bartlomiej P Przychodzen5*, Kristbjorn O Gudmundsson, PhD3*, Bandana A Vishwakarma, PhD3*, Andres Jerez, MD6*, Ines Gomez-Segui, MD7*, Mariko Takahashi, MD8*, Yuichi Shiraishi, PhD2*, Yasunobu Nagata, MD2*, Kathryn M Guinta9*, Hiraku Mori, MD, PhD10*, Mikkael A. Sekeres, MD, MS1, Kenichi Chiba, BA11*, Hideki Muramatsu, MD, PhD12*, Hirotoshi Sakaguchi, MD12*, Ronald Paquette, MD, PhD13*, Michael A McDevitt, MD, PhD14, Seiji Kojima15*, Yogen Saunthararajah, MD4, Satoru Miyano, PhD2*, Lee-Yung Shih, MD, PhD16, Yang Du, PhD3*, Seishi Ogawa, MD, PhD2 and Jaroslaw P. Maciejewski, MD, PhD1

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
3Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD
4Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
6Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
7Translational Hem/Onc Research, Cleveland Clinic, Cleveland, OH
8Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
9Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
10Department of Hematology, Showa University, Tokyo, Japan
11Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
13UCLA Division of Hematology/Oncology, Los Angeles, CA
14Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
15Nagoya University Graduate School of Medicine, Nagoya, Japan
16Chang Gung Memorial Hospital, Taipei, Taiwan

2:40 PM

Robert A. Hromas, MD

Chairman’s Office/Dept. of Medicine, University of Florida College of Medicine, Gainesville, FL

2:45 PM

Kimberly Cramer, Ph.D.1*, Margaret Nieborowska-Skorska, MD, PhD1*, Artur Slupianek, PhD1*, Tomasz Sliwinski2*, David Irvine3*, Mhairi Copland, PhD, BSc, MRCP, FRCPath4 and Tomasz Skorski, MD, PhD1

1Department of Microbiology & Immunology, Temple University School of Medicine, Philadelphia, PA
2University of Lodz, Lodz, Poland
3Gartnavel General Hospital Section of Experimental Haem., University of Glasgow, Glasgow, United Kingdom
4Cancer Division, University of Glasgow, Glasgow, United Kingdom

3:00 PM

Claire N Harrison, DM FRCP FRCPath

Guy's and St Thomas' NHS FoundationTrust, London, United Kingdom

3:05 PM

Tiziano Barbui, MD1*, Monia Lunghi, M.D.2*, Alessia Tieghi, M.D.3*, Guido Finazzi, MD1*, Roberto Latagliata, MD4*, Valerio De Stefano, MD5*, Rossella Cacciola, M.D.6*, Caterina Musolino, MD7*, Marco Ruggeri, MD8, Emilio Usala9*, Giorgina Specchia10, Elisa Rumi, MD11*, Maria Luigia Randi12*, Alessandra Iurlo, M.D.13*, Alessandro M. Vannucchi, MD14, Davide Rapezzi15*, Anna Rita Scortechini, MD16*, Francesca Lunghi, MD17*, Maria Carmen Martorelli18*, Daniela Cilloni, MD19, Michele Nobile, MD20*, Sergio Siragusa, MD21, Simone Santini22*, Elena Elli23*, Giuseppe Visani24*, Giovanni Quarta, MD25*, Antonio Spadea26*, Rosa Maria Marfisi27*, Arianna Masciulli, BSc27* and Roberto Marchioli, MD27*

1USC Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy
2Division of Hematology, Department of Clinical and Experimental Medicine & IRCAD, Amedeo Avogadro University Hospital, Novara, Novara, Italy
3Hematology Unit, Arcispedale S.Maria Nuova
4Hematology, Sapienza University, Rome, Italy
5GIMEMA Italian Myeloma Network, Roma, Italy
6Biomedical Science, Section of Hematology, University of Catania, Catania, Italy
7Hematology Section, University of Messina, Messina, Italy
8S. Bortolo Hospital, Vicenza, Italy
9Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico Armando Businco, Cagliari, Italy
10Department of Hematology, University of Bari, Bari, Italy
11Department of Hematology Oncology, FFondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
12University of Padua, Italy
13Division of hematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
14University of Florence, Florence, Italy
15A.O. S.Croce e Carle, Cuneo, Cuneo
16Hematology, OSPEDALI RIUNITI DI ANCONA, Ancona, Italy
17Haematology and Bone Marrow Transplantation Unit - EBMT cic 813, San Raffaele Scientific Institute, Milan, Italy
18Department of Onco-Hematology, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (PZ), Italy
19Division of Internal Medicine & Hematology, University of Turin-San Luigi Gonzaga Hospital, Orbassano, Turin, Italy
20Casa Sollievo della Sofferenza San Giovanni Rotondo
21Cattedra ed U.O. di Ematologia, Università degli Studi di Palermo, Palermo, Italy
22Ospedale di Prato
23Ospedale San Gerardo di Monza
24Division of Hematology, Pesaro, Italy
25Division of Hematology, Ospedale A. Perrino, Brindisi, Italy
26Hematology, IFO, Rome, Italy
27Istituto Mario Negri Sud, S. Maria Imbaro, Italy

3:20 PM

Matthew J. Walter, MD

Oncology, Washington University in St. Louis, St. Louis, MO

3:25 PM

Dan-Avi Landau, MD1,2,3, Scott Carter3*, Petar Stojanov3*, Kristen E. Stevenson, MS4*, Aaron Mckenna, PhD3*, Michael Lawrence, Ph.D.3*, Carrie Sougnez3*, Andrey Sivachenko3*, Lili Wang, M.D., Ph.D.2*, Wandi Zhang2*, Shukla Sachet2*, Alexander R. Vartanov, BS5*, Stacey M. Fernandes2*, Kristian Cibulskis3*, Bethany Tesar2*, Stacey Gabriel3*, Matthew Meyerson, MD, PhD2*, Eric S. Lander, PhD3*, Donna S. Neuberg, ScD6, Jennifer R. Brown, MD, PhD5,7, Gad Getz, Ph.D.3* and Catherine J. Wu, MD8

1Yale Cancer Center, Yale University, New Haven, CT
2Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
3Broad Institute, Cambridge, MA
4Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6Department of Biostatistics, Dana Farber Cancer Institute, Boston, MA
7Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
8Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

3:40 PM

Pierre Fenaux, MD, PhD

Hematology Department, AP-HP, Hôpital Avicenne, Université Paris 13, France

3:45 PM

Francesco Lo-Coco, MD1, Giuseppe Avvisati, MD, PhD2*, Sonia Maria Orlando3*, Felicetto Ferrara, MD4, Marco Vignetti, MD5*, Paola Fazi, MD6*, Eros Di Bona, MD7*, Giorgina Specchia, MD8*, Simona Sica, MD9*, Mariadomenica Divona10*, Alessandro Levis, MD11, Walter Fiedler, MD12, Elisa Cerqui, MD13*, Massimo Breccia14*, Giuseppe Fioritoni, MD15*, Helmut R Salih, MD16, Christian H. Brandts17*, Enrica Morra, MD18, Marie von Lilienfeld-Toal, MD19*, Bernd Hertenstein20*, Mohammed Wattad, MD21, Michael Lubbert, MD22, Matthias Hänel, MD23*, Norbert Schmitz, MD24, Hartmut Link, MD25*, Maria Grazia Kropp, MD26*, Alessandro Rambaldi, MD27, Giorgio La Nasa, MD28*, Mario Luppi29*, Fabio Ciceri, MD30*, Michaela Sauer31*, Hartmut Dohner, MD32, Arnold Ganser33, Franco Mandelli, MD34, Gerhard Ehninger35, Sergio Amadori, MD36*, Christian Thiede35, Richard F Schlenk, MD32 and Uwe Platzbecker, MD37

1Hematology, University Tor Vergata, Roma, Italy
2Hematology, Campus Biomedico University, Rome, Italy
3GIMEMA, Roma, Italy
4Hematology and Stem cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
5GIMEMA Data Center, GIMEMA Foundation, Roma, Italy
6GIMEMA, Rome, Italy
7Hematology, Ospedale S. Bortolo, Vicenza, Italy
8Department of Hematology, University of Bari, Bari, Italy
9Hematology, Policlinico Gemelli, Università Cattolica, Roma, Italy
10Policlinico Universitario Tor Vergata, Rome, Italy
11OSPEDALE CIVILE, Alessandria, Italy
12Hubertus Wald University Cancer Center, Department of Oncology and Hematology, University Medical Center Eppendorf, Hamburg, Germany
13Hematology Division, Spedali Civili, Brescia, Italy
14Department of Biotechnologies and Hematology, University of Rome “Sapienza”, Rome, Italy
15Hematology, Pescara, Italy
16Abteilung II für Onkologie, Hämatologie, Immunologie, Rheumatologie und Pulmologie, Medizinische Universitätsklinik Tübingen, Tübingen, Germany
17Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany
18Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
19Department of Internal Medicine III, University Hospital of Bonn, Bonn, Germany
20Hämatologie und Onkologie, Klinikum Bremen Mitte, Bremen, Germany
21Kliniken Essen Süd, Essen, Germany
22University Hospital Freiburg, Freiburg, Germany
23Klinikum Chemnitz gGmbH, Chemnitz, Germany
24Abteilung f. Hämatologie, Onkologie und Stammzelltransplantation, Asklepios Klinik St. Georg Hamburg, Hamburg, Germany
25Department of Medicine I, Westpfalzklinikum, Kaiserslautern, Germany
26Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy
27Hematology, Ospedali Riuniti, Bergamo, Italy
28Department of Internal Medicine, Centro Trapianti Midollo Osseo, Ospedale R. Binaghi, Cagliari, Italy
29Bone Marrow Transplant Unit, Department of Oncology and Hematology, University of Modena, Modena, Italy
30Hematology and BMT Unit, San Raffaele Scientific Institute, Milan, Italy
31Universitatsklinikum Carl Gustav Carus, Dresden, Germany
32Internal Medicine III, University of Ulm, Ulm, Germany
33Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
34Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy
35Universitätsklinikum Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany
36University Tor Vergata, 00133, Italy
37Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

*signifies non-member of ASH